SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 57 filers reported holding SAVARA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $855,146 | +11.7% | 226,229 | -5.6% | 0.00% | 0.0% |
Q2 2023 | $765,704 | +89.1% | 239,657 | +15.4% | 0.00% | +100.0% |
Q1 2023 | $404,910 | +49.2% | 207,646 | +18.6% | 0.00% | 0.0% |
Q4 2022 | $271,363 | +2.0% | 175,073 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $266,000 | +20.9% | 171,915 | +19.0% | 0.00% | +100.0% |
Q2 2022 | $220,000 | +24.3% | 144,432 | +6.9% | 0.00% | 0.0% |
Q1 2022 | $177,000 | -5.9% | 135,069 | -10.8% | 0.00% | 0.0% |
Q4 2021 | $188,000 | -16.8% | 151,399 | -7.4% | 0.00% | 0.0% |
Q3 2021 | $226,000 | -7.4% | 163,545 | +13.9% | 0.00% | 0.0% |
Q2 2021 | $244,000 | +229.7% | 143,582 | +303.0% | 0.00% | – |
Q1 2021 | $74,000 | – | 35,628 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |